awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36778047-1FF25B25-10D9-494D-88C2-A1F49CFC9B17
Q36778047-1FF25B25-10D9-494D-88C2-A1F49CFC9B17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36778047-1FF25B25-10D9-494D-88C2-A1F49CFC9B17
Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.
P2860
Q36778047-1FF25B25-10D9-494D-88C2-A1F49CFC9B17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36778047-1FF25B25-10D9-494D-88C2-A1F49CFC9B17
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
af5591249895d3db7f8431f38599afcf7c27c184
P2860
Gemcitabine: once-weekly schedule active and better tolerated than twice-weekly schedule.